A Pharmacometrics-Informed Trial Simulation Framework for Optimizing Study Designs for Disease-Modifying Treatments in Rare Neurological Disorders. [PDF]
Ryeznik Y +12 more
europepmc +1 more source
Overexpression of KMT9α is associated with poor outcome in cholangiocarcinoma patients. [PDF]
Kinzler MN +13 more
europepmc +1 more source
KDM4A promotes NEPC progression through regulation of MYC expression. [PDF]
Mak CSL +37 more
europepmc +1 more source
Neuropilin-1 expression modulates infection susceptibility to murine cytomegalovirus at the materno-fetal interface. [PDF]
Fonseca Brito L +8 more
europepmc +1 more source
The use of high-velocity, low-amplitude techniques in paediatric osteopathic care: two multinational cross-sectional surveys on clinical practice and educational curricula. [PDF]
van Dun PLS +6 more
europepmc +1 more source
Sensitization of Non-M3 Acute Myeloid Leukemia Blasts to All-Trans Retinoic Acid by the LSD1 Inhibitor Tranylcypromine: TRANSATRA Phase I Study. [PDF]
Kruszewski M +22 more
europepmc +1 more source
An Investigation of Corticospinal Tract Microstructural Integrity in ARSACS Using a Profilometry MRI Analysis: Results From the PROSPAX Study. [PDF]
Scaravilli A +17 more
europepmc +1 more source
Mitochondrial KMT9 methylates DLAT to control pyruvate dehydrogenase activity and prostate cancer growth. [PDF]
Jia Y +18 more
europepmc +1 more source

